Evidence map›Paper›PMID 33247675›Full record

ArticleAsian Pacific journal of cancer prevention : APJCP2020

The Sensitivity and Specificity of Novel Primers for Detection of BRAFV600E Mutation.

Bizhar A Tayeb, Howard J Pringle

Abstract read
In one paragraph

Article in Asian Pacific journal of cancer prevention : APJCP, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Bizhar A TayebMolecular Pathology and Toxicology, Department of Molecular Microbiology, Central Laboratory in Ibrahim Al-khalil Zakho, Duhok, Kurdistan Region of Iraq.ORCID 0000-0001-5197-564X
Howard J PringleDepartment of Cancer Studies and Molecular Medicine, University of Leicester, Leicester, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThis study aimed to evaluate the sensitivity and specificity of a PCR-based novel technique for the detection of BRAF mutation in early stages of the cancer.

methodsDifferent lengths of primer sets, ranging from 8 bp to 20 bp, were designed and used in this study. These primers were developed by applying on  cancer cell lines. After that, the sensitivity and specificity of the methodology  was evaluated by making serial dilutions.

resultsThe quantitative allele specific discrimination PCR (QUASAqPCR) primer with 14 bp length was sensitive enough to detect significantly 1:1,000 ratio of BRAFV600E to wild-type background  (P = 0.011), when using 150 nanograms of DNA from cell lines in the reactions.

conclusionHigh sensitivity and specificity levels of QUASA-qPCR method can improve diagnostic accuracy for BRAF mutation testing in patients at early stages of cancers and help stratify the appropriate choice of treatment.

Indexed as

MutationDNA PrimersHumansNeoplasmsProto-Oncogene Proteins B-rafReal-Time Polymerase Chain ReactionROC CurveTumor Cells, CulturedBRAF protein, humanDNA PrimersProto-Oncogene Proteins B-rafBRAFV600Eearly detectionLow abundancePrimer sensitivityQUASA-qPCR

Identifiers

PMID33247675
PMCPMC8033103

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.